Drug Profile
Testosterone buccal - INNOTESTO
Alternative Names: BuccaronLatest Information Update: 13 Nov 2021
Price :
$50
*
At a glance
- Originator INNOTESTO bvba
- Class Anabolic steroids; Androstenols; Erectile dysfunction therapies; Hormonal replacements; Small molecules; Testosterone congeners
- Mechanism of Action Androgen receptor agonists; Testosterone replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II/III Hypogonadism
Most Recent Events
- 06 Feb 2018 Chemical structure information added
- 17 Jan 2018 Phase II/III development is ongoing (INNOTESTO pipeline, January 2018)
- 08 Dec 2015 Phase-II/III clinical trials in Hypogonadism (In the elderly) in Belgium (Buccal)